Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)

ClinicalTrials.gov ID: NCT01470469

Public ClinicalTrials.gov record NCT01470469. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 2:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Tolerability of SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP).

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the safety and tolerability of SPD503 in subjects aged 6-17 years with GAD, SAD, or SoP based on treatment emergent adverse events (TEAEs), vital signs and ECGs.

Study identification

NCT ID
NCT01470469
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Shire
Industry
Enrollment
83 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 4, 2012 (Actual)
Primary completion
Jul 15, 2013 (Actual)
Completion
Jul 15, 2013 (Actual)
Last update posted
Jun 10, 2021

2012 – 2013

United States locations

U.S. sites
33
U.S. states
19
U.S. cities
32
Facility City State ZIP Site status
Birmingham Research Group, Inc Birmingham Alabama 35216 —
Dr. Joseph H. Rodd Carson California 90746 —
Sun Valley Research Imperial California 92251 —
Irvine Center for Clinical Research Irvine California 92618 —
Sharp Mesa Vista Hospital, Clinical Research Department San Diego California 92123 —
Elite Clinical Trials, Inc Wildomar California 92595 —
Florida Clinical Research Center Bradenton Florida 34201 —
Sarkis Clinical Trials Gainesville Florida 32607 —
Kolin Research Group Winter Park Florida 32789 —
Atlanta Center for Medical Research Atlanta Georgia 30308 —
Institute of Behavioral Medicine, LLC Smyrna Georgia 30080-6315 —
Lake Charles Clinical Trials Lake Charles Louisiana 70629 —
Rochester Center for Behavioral Medicine Rochester Hills Michigan 48307 —
Midwest Research Group Saint Charles Missouri 63301 —
Premier Psychiatric Group, LLC Lincoln Nebraska 68526 —
Center for Psychiatry and Behavioral Medicine, Inc Las Vegas Nevada 89128 —
Center for Emotional Fitness Cherry Hill New Jersey 08002 —
Columbia University, NY State Psychiatric Institute New York New York 10032 —
Weill Cornell Medical Center New York New York 10065 —
Finger Lakes Clinical Research Rochester New York 14618 —
Richmond Behavioral Associates Staten Island New York 10312 —
Duke University Medical Center, Duke Child and Family Study Center Durham North Carolina 27705-4596 —
University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience Cincinnati Ohio 45219 —
University Hospitals of Cleveland Medical Center Cleveland Ohio 44012 —
Professional Psychiatric Services Mason Ohio 45040 —
North Star Research Middleburg Heights Ohio 44130 —
IPS Research Company Oklahoma City Oklahoma 73103 —
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464 —
Research Strategies of Memphis, LLC Memphis Tennessee 38119 —
FutureSearch Clinical Trials, LP Austin Texas 78731 —
Houston Clinical Trials LLC Houston Texas 77098 —
Ericksen Research and Development Clinton Utah 84015 —
NeuroScience, Inc. Herndon Virginia 20170 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01470469, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 10, 2021 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01470469 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →